News Industry News Mast Therapeutics Initiates Phase 2 Study Of Vepoloxamer For The Treatment Of Chronic Heart Failure October 26, 2015
News Daily News New CMR-Identified Myocardial Injury Post-TAVR Linked With Decreased LV Function Yael L. Maxwell July 24, 2014